MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)

    Objective: Parkinson’s disease patients with apathy and patients in the medication OFF state show reduced reward sensitivity in effort-based decision-making tasks. The effect of subthalamic…
  • 2023 International Congress

    The neuroprotective properties of NLX-112 in MPTP treated mice are mediated by reactive gliosis and astrocytic GDNF

    W. Powell, A. Newman-Tancredi, L. Annett, R. Depoortere, M. Iravani (Hatfield, United Kingdom)

    Objective: To investigate whether NLX-112, a potent and selective 5-HT1A agonist is neuroprotective in a mouse MPTP model of Parkinson’s Disease (PD) [1]. Background: There…
  • 2023 International Congress

    Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects

    J. Janssen Daalen, M. Meinders, F. Giardina, S. Mathur, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: In this study, we describe the safety and short-term effects of the first hypoxia-based treatment trial in Parkinson’s disease by deploying a personalized multiple…
  • 2023 International Congress

    Combination COMT inhibitor with Levodopa reduces consumption of vitamin B6

    D. Kamiyama, N. Nishikawa, S. Ueno, C. Abe, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate changes in Levodopa (LD) pharmacokinetics and changes in homocysteine, vitamin B6, and vitamin B12 in Parkinson's disease (PD) patients receiving LD formulations…
  • 2023 International Congress

    Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems

    M. de Neeling, M. Stam, B. van Wijk, J. Anso, R. Raike, P. Schuurman, R. de Bie, A. Buijink, M. Beudel (Amsterdam, Netherlands)

    Objective: To study the relationship between oscillatory beta activity in the subthalamic nucleus (STN) and the intake of dopaminergic medication in a group of Parkinson’s…
  • 2023 International Congress

    Fragile X Related Tremor in FMR1 Premutation Women without FXTAS

    D. Hall, T. Svymbersky, J. O'Keefe, B. Ouyang, E. Berry-Kravis (Chicago, USA)

    Objective: To determine whether there is a FMR1 premutation associated tremor in women who do not meet criteria for Fragile X-associated tremor ataxia syndrome (FXTAS)…
  • 2023 International Congress

    Response to Levodopa in Parkinson´s Disease Over Time. A 4-year Follow-up Study.

    D. Santos García, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, F. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the response to levodopa in Parkinson´s disease (PD) patients with motor fluctuations followed up for…
  • 2023 International Congress

    Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

    O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)

    Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson's disease (PD) severity, and to compare them with a…
  • 2023 International Congress

    Clinical spectrum, imaging characteristics and care giver burden assessment of early onset non-dominant progressive cerebellar ataxias

    R. Devaraj, P. Pal, N. M, RY. Yadav, M. Faruq, J. Saini, S. Hegde (Bangalore, India)

    Objective: To characterise the phenotypic and radiological spectrum of patients with early onset non-dominant progressive cerebellar ataxias and to assess the impact of the disease…
  • 2023 International Congress

    Musical Perception in Parkinson’s Disease, a Pilot Study

    K. Vourou (Athens, Greece)

    Objective: This pilot study aimed to investigate whether patients with PD have deficits in the perception of melody, rhythm, and musical excerpt recognition as measured…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley